Chaum Global Stem Cell Clinical Trials Center

CHA Stem Cell Institute

The CHA Stem Cell Institute researches both adult stem cell pipelines as well as embryonic stem cell pipelines in unison with the world’s leading universities and research scholars in order to be the leaders in curing various incurable diseases.


15 Improved modalities for the treatment of degenerative diseases of the retina.US 06/0018886, WO 06/080952)
14 Improved methods of producing rpe cells and compositions of rpe cells. PCT/US2008/011669
13 A method of treating retinal degeneration, comprising: differentiating human embryonic stem cells ex vivo to produce RPE cells; isolating the RPE cells. US 06/0031951
12 Hemangio-Colony Forming Cells, WO 2007/120811A2, PCT/US2007/009106
11 Non-Engrafting Hemangio Cells. U.S. Patent (Serial No. not provided)
10 Methods for Producing Enucleated Erythroid Cells Derived from Pluripotent Stem Cells. U.S. Patent Application (Serial No. not provided)
9 Hemangio-Colony Forming Cells. U.S. Patent Application (Serial No. not provided)
8 Methods for vitrification of human oocytes (US 10/581260)
7 Method for culturing human embryonic stem cells (US 12/227,793, EP 7746787.6, JP2009-513061)
6 Process for isolating vascular endotheliar cells from embryoid bodies differenciated from embryonic stem cells (PCT/KR2007/002840, US 11/913,295)

첫페이지 이전페이지 이동 1 2 다음페이지 이동 마지막페이지